Lundquist Institute for Biomedical Innovation — Torrance, California

Public research footprint of Lundquist Institute for Biomedical Innovation, compiled from the ClinicalTrials.gov public registry.

138

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Classic Hodgkin Lymphoma · Recurrent B Acute Lymphoblastic Leukemia · Recurrent Langerhans Cell Histiocytosis · Recurrent Malignant Solid Neoplasm

Recently updated registry entries

NCT06081894 — A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults… (Active Not Recruiting)
NCT06065748 — A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a… (Recruiting)
NCT06909565 — Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Lundquist Institute for Biomedical Innovation?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.